What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
The scientist’s investigation covers issues in Internal medicine, Transplantation, CD34, Stem cell and Myelodysplastic syndromes.
Rainer Haas has included themes like Gastroenterology, Surgery and Oncology in his Internal medicine study.
Rainer Haas works mostly in the field of Transplantation, limiting it down to topics relating to Salvage therapy and, in certain cases, Azacitidine, Complication and Corticosteroid.
His studies in CD34 integrate themes in fields like Progenitor cell, Haematopoiesis, Bone marrow and Cellular differentiation.
The various areas that Rainer Haas examines in his Stem cell study include Cancer research and T-cell receptor.
His study on International Prognostic Scoring System is often connected to European standard as part of broader study in Myelodysplastic syndromes.
His most cited work include:
- Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. (237 citations)
- Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation (147 citations)
- Phase III study of all- trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia (141 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Myelodysplastic syndromes, Oncology, Transplantation and Immunology.
The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine.
The Myelodysplastic syndromes study combines topics in areas such as Hematology, Pediatrics, Induction chemotherapy and Cohort.
Rainer Haas usually deals with Oncology and limits it to topics linked to Azacitidine and Decitabine.
His Transplantation research is multidisciplinary, relying on both Leukemia, Salvage therapy, Stem cell and Multiple myeloma.
His Immunology study combines topics in areas such as Progenitor cell, CD34 and Haematopoiesis.
He most often published in these fields:
- Internal medicine (55.22%)
- Myelodysplastic syndromes (27.48%)
- Oncology (26.72%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (55.22%)
- Oncology (26.72%)
- Myelodysplastic syndromes (27.48%)
In recent papers he was focusing on the following fields of study:
Rainer Haas mostly deals with Internal medicine, Oncology, Myelodysplastic syndromes, Transplantation and Myeloid leukemia.
His Internal medicine study frequently draws connections between adjacent fields such as Azacitidine.
His study on Oncology also encompasses disciplines like
- Minimal residual disease which intersects with area such as Hematopoietic stem cell,
- Myeloid which intersects with area such as Leukemia and Neuroblastoma RAS viral oncogene homolog.
As part of the same scientific family, Rainer Haas usually focuses on Myelodysplastic syndromes, concentrating on Cohort and intersecting with Hazard ratio and Gastroenterology.
While the research belongs to areas of Transplantation, Rainer Haas spends his time largely on the problem of Stem cell, intersecting his research to questions surrounding Granulocyte colony-stimulating factor.
His research in Myeloid leukemia tackles topics such as Bone marrow which are related to areas like Haematopoiesis, Cancer research and Cell.
Between 2015 and 2021, his most popular works were:
- Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia. (70 citations)
- Reduced DNA methylation patterning and transcriptional connectivity define human skin aging (45 citations)
- Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group (39 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Internal medicine, Myelodysplastic syndromes, Oncology, Myeloid leukemia and Myeloid are his primary areas of study.
A large part of his Internal medicine studies is devoted to Hematology.
His Myelodysplastic syndromes study integrates concerns from other disciplines, such as Neuroblastoma RAS viral oncogene homolog and Median survival.
His Oncology research is multidisciplinary, incorporating perspectives in Univariate analysis, Hematopoietic stem cell transplantation, Transplantation and Minimal residual disease.
His biological study spans a wide range of topics, including Stem cell and Allogeneic transplantation.
His Myeloid research entails a greater understanding of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
